Foghorn Therapeutics FHTX
NASDAQ FHTX
$4.91 +0.05 (+0.92%)
As of: Sep 4, 2026 · 2:26 PM EDT

Foghorn Therapeutics (FHTX) Times Interest Earned (2019 - 2021)

Foghorn Therapeutics (FHTX) posted quarterly Times Interest Earned of -$0.35 for Q1 2026, up 95.72% year-over-year from -$0.18 in Q1 2025, and up 97.5% quarter-over-quarter from -$14.19 in Q4 2025.

Analysis

Foghorn Therapeutics (FHTX) Times Interest Earned (2019 - 2021) Analysis & Trends

Foghorn Therapeutics' Times Interest Earned history runs 8 years deep, the most recent figure standing at -$0.35 for Q1 2026.

  • In Q1 2026, Times Interest Earned rose 95.72% year-over-year to -$0.35; the TTM figure through Mar 2026 stood at -$1.4 (up 92.81% YoY), while the FY2025 annual figure was -$0.46, up 25.38% from the prior year.
  • Times Interest Earned for Q1 2026 stood at -$0.35, up from -$14.19 in the prior quarter.
  • The five-year high for Times Interest Earned was $3.1 in Q4 2024, with the low at -$954.08 in Q3 2024.
  • The 5-year median for Times Interest Earned is -$9.02 (2023), against an average of -$77.92.
  • Peak annual rise in Times Interest Earned reached 1841.25% in 2024, while the deepest fall reached 10479.17% in 2024.
  • Foghorn Therapeutics' Times Interest Earned stood at -$3.19 in 2022, then jumped by 94.42% to -$0.18 in 2023, then surged by 1841.25% to $3.1 in 2024, then plunged by 557.58% to -$14.19 in 2025, then jumped by 97.5% to -$0.35 in 2026.
  • Business Quant data shows FHTX's Times Interest Earned at -$0.35 in Q1 2026, -$14.19 in Q4 2025, and -$0.73 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn 117.59
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -493.00
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn -
5 Revolution Medicines 44.07 Bn 44.07 Bn - -21.24
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.42 Bn 27.58 Bn - 1.42
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn -0.08
10 Foghorn Therapeutics 347.14 Mn 279.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -65.92
Sep 30, 2021 -52.63
Jun 30, 2021 -46.99
Mar 31, 2021 -47.59
Dec 31, 2020 -64.73
Sep 30, 2020 -91.53
Jun 30, 2020 -78.48
Mar 31, 2020 -53.19
Dec 31, 2019 -85.31
Sep 30, 2019 -115.93